Metagenomi, Inc. (MGX)
NASDAQ: MGX · Real-Time Price · USD
1.515
+0.015 (1.00%)
May 15, 2025, 1:10 PM - Market open

Metagenomi Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2024 FY 2023 FY 2022 FY 2021
Period Ending
Mar '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-77.95-78.06-68.26-43.59-21.44
Depreciation & Amortization
5.495.414.211.730.39
Asset Writedown & Restructuring Costs
1.041.040.020.28-
Loss (Gain) From Sale of Investments
3.233.02-11.34-1.22-2.56
Stock-Based Compensation
14.0816.26.921.960.38
Other Operating Activities
3.082.983.471.081.24
Change in Accounts Receivable
1.071.19-1.18-1.27-
Change in Accounts Payable
-2.06-1.11-0.080.720.7
Change in Unearned Revenue
-39.49-46.8-30.365.6644.23
Change in Income Taxes
-3.27-3.271.731.54-
Change in Other Net Operating Assets
-7.29-9.693.42.841.33
Operating Cash Flow
-102.07-109.07-91.4129.7224.26
Operating Cash Flow Growth
---22.54%-
Capital Expenditures
-2.49-3.11-9.81-13.98-2.9
Investment in Securities
33.79-85.0455.55-108.22-71.41
Investing Cash Flow
31.3-88.1645.73-122.2-74.32
Long-Term Debt Issued
----29.97
Net Debt Issued (Repaid)
----29.97
Issuance of Common Stock
-84.01---
Other Financing Activities
-0.08--3.28--
Financing Cash Flow
-2.684.011.01239.5939.92
Net Cash Flow
-73.36-113.22-44.66147.12-10.14
Free Cash Flow
-104.55-112.19-101.2215.7521.35
Free Cash Flow Growth
----26.26%-
Free Cash Flow Margin
-230.99%-214.53%-226.17%91.55%8787.65%
Free Cash Flow Per Share
-2.83-3.40-29.734.633.75
Cash Interest Paid
---2.161.45
Cash Income Tax Paid
3.513.512.25--
Levered Free Cash Flow
-68.74-73.35-31.65-19.71-
Unlevered Free Cash Flow
-68.74-73.35-31.65-19.65-
Change in Net Working Capital
31.0236.28-16.09-18.53-
Updated May 13, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q